US-based middle-market private credit firm Colbeck Capital Management has announced its continued support for the Children's Tumor Foundation in recognition of World NF Awareness Day, which brings global attention to neurofibromatosis and schwannomatosis (collectively known as NF), a group of genetic conditions that cause tumors to grow on nerves throughout the body, the firm said.

World NF Awareness Day is observed annually on May 17 and serves as the centerpiece of NF Awareness Month.

The day brings together patients, families, researchers, and advocates around the world to highlight the experiences of those living with NF and to reinforce the importance of sustained investment in research.

In 2026, CTF's NF Awareness Month campaign has expanded to include global landmark lightings, awareness initiatives, educational programming, and community-driven efforts designed to increase visibility for NF and deepen understanding of the impact of the condition on individuals and families.

The support of partners such as Jason Colodne and Colbeck Capital is instrumental in advancing CTF's efforts to accelerate research, expand public understanding, and improve care for the NF community.

Founded in 1978, the Children's Tumor Foundation is the leading drug discovery engine for NF. CTF accelerates the delivery of treatments to patients by convening clinicians, scientists, pharmaceutical partners, and affected families in pursuit of a shared mission to end NF.

Through a patient-first, collaborative model, CTF advances drug development and brings life-changing therapies to individuals living with neurofibromatosis and schwannomatosis.

Colbeck Capital Management is middle-market private credit manager focused on strategic lending.

Colbeck lends to companies going through periods of transition, providing creative capital solutions and risk mitigation strategies.